Asia Green Biotechnology (XCNQ:ASIA) Retained Earnings : C$-3.15 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Asia Green Biotechnology Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Asia Green Biotechnology's retained earnings for the quarter that ended in Dec. 2023 was C$-3.15 Mil.

Asia Green Biotechnology's quarterly retained earnings declined from Jun. 2023 (C$-3.01 Mil) to Sep. 2023 (C$-3.03 Mil) and declined from Sep. 2023 (C$-3.03 Mil) to Dec. 2023 (C$-3.15 Mil).

Asia Green Biotechnology's annual retained earnings declined from Dec. 2021 (C$-2.77 Mil) to Dec. 2022 (C$-2.93 Mil) and declined from Dec. 2022 (C$-2.93 Mil) to Dec. 2023 (C$-3.15 Mil).

Asia Green Biotechnology Retained Earnings Historical Data

The historical data trend for Asia Green Biotechnology's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asia Green Biotechnology Retained Earnings Chart

Asia Green Biotechnology Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Retained Earnings

Get a 7-Day Free Trial

-1.69

-2.24

-2.77

-2.93

-3.15

Asia Green Biotechnology Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Retained Earnings	Get a 7-Day Free Trial															-2.93	-2.98	-3.01	-3.03	-3.15

Asia Green Biotechnology Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Asia Green Biotechnology (XCNQ:ASIA) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Asia Green Biotechnology (XCNQ:ASIA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Asia Green Biotechnology Corp (XCNQ:ASIA) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

N/A

Address

707 - 7th Avenue SW, Suite 1150, Calgary, AB, CAN, T2P 3H6

Website

https://www.asiagreenbiotechnology.com

Asia Green Biotechnology Corp is an early stage international agri-technology company focused on the development, evaluation, testing, application and, ultimately, supply to the market of proprietary organic hybridization technology and certain products derived from that technology. The core approach of the business is centred on the planting, growth and harvesting of new and valuable strains of hemp and related crops in commercial quantities. The company is developing varieties of hemp with superior growth and production characteristics in the various environments found in the licensed territories.

Executives

Johannes Kingma

Senior Officer